Paranjeet Kaur

Dr. Paranjeet Kaur


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
ACAvik Chandra
Avik Chandra
PKParanjeet Kaur
Paranjeet Kaur
SSSanjeev Kumar Sahu
Sanjeev Kumar Sahu
AMAmit Mittal
Amit Mittal

30 June 2022 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
AVAnil Verma
Anil Verma
BKBalwinder Kaur
Balwinder Kaur
SVSneha Venugopal
Sneha Venugopal
PWPANKAJ WADHWA
PANKAJ WADHWA
SSSanjeev Kumar Sahu
Sanjeev Kumar Sahu
DSDr Ajit Kumar Sharma
Dr Ajit Kumar Sharma

20 July 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MAMustafiz Ansari
Mustafiz Ansari
SSSanjeev Kumar Sahu
Sanjeev Kumar Sahu
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
SSSovia R.J. Singh
Sovia R.J. Singh
PKParanjeet Kaur
Paranjeet Kaur

24 December 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
DPDeepshikha Patle
Deepshikha Patle
NKNavneet Khurana
Navneet Khurana
JBJeena Gupta Bansal
Jeena Gupta Bansal
PKParanjeet Kaur
Paranjeet Kaur
GKGopal L. Khatik
Gopal L. Khatik

1 September 2021 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BBBetty Matimba Buumba
Betty Matimba Buumba
SBShweta Bhardwaj
Shweta Bhardwaj
PKParanjeet Kaur
Paranjeet Kaur
Background: The most documented illness affecting women overall is breast malignant growth. Since breast cancer disease is the most widely recognized threat in women, Since breast cancer disease is the most widely recognized threat in women, this review was done to provide data on the ongoing advancements in the medication focused on in the breast cancer regimen. Over the previous decades, it has been seen that different progressions have been made in the disclosure of new medications and treatments for treating breast malignancy and this is a direct result of the improved comprehension of the biologic heterogeneity of breast cancer, which has likewise permitted the advancement of increasingly compelling ways to deal with treating breast cancer. Methods: We searched the scientific database using relevant keywords. Among the searched literature, only peer-reviewed papers were collected, which address our questions. The retrieved quality papers were screened and analyzed critically. The key findings of these studies are included along with the importance. Results: The research in this review particularly includes the anti-breast cancer drugs, which accountfor the top largest market by sales in the pharmaceutical industry. Apart from these, natural and innovative therapies have emerged leading to better management of breast cancer. Conclusion: These recent developments have contributed to a more efficient and specific treatment protocol in breast cancer patients. Moreover, further investigation should be done in improving results for all the patients with breast cancer disease, particularly individuals who have advanced breast cancer and the issue of drug resistance, which also poses a threat to the successful development of targeted therapy in various subtypes of breast cancer, must also be considered.

1 January 2023 in AIP Conference Proceedings
Verified
Conference Paper
Open access
PDF file
TKTarun Khattar
Tarun Khattar
PGPilli Govindaiah
Pilli Govindaiah
AMAbhijeet Mishra
Abhijeet Mishra
MAM. D. Mustafiz Ansari
M. D. Mustafiz Ansari
PKParanjeet Kaur
Paranjeet Kaur
Scientists began exploring for new compounds to tackle the illness because current medications were ineffectual and had negative effects and toxicity in people.